LONDON--(BUSINESS WIRE)--LivaNova PLC (NASDAQ:LIVN; LSE: LIVN) (“LivaNova” or the “Company”), a market-leading medical technology and innovation company, today announced that Vivid Sehgal, Chief Financial Officer of LivaNova, will be presenting at the Berenberg European Conference in the United Kingdom on Wednesday, December 7, 2016 at 9:45 a.m.
LivaNova PLC is a global medical technology company formed by the merger of Sorin S.p.A, a leader in the treatment of cardiovascular diseases, and Cyberonics Inc., a medical device company with core expertise in neuromodulation. LivaNova transforms medical innovation into meaningful solutions for the benefit of patients, healthcare professionals, and healthcare systems.
The Company employs approximately 4,600 employees worldwide and is headquartered in London, U.K.
For more information, please visit www.livanova.com.